登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 4674 条符合本次的查询结果， 用时 5.401684 秒

4261. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.

作者: Brett King.;Xingqi Zhang.;Walter Gubelin Harcha.;Jacek C Szepietowski.;Jerry Shapiro.;Charles Lynde.;Natasha A Mesinkovska.;Samuel H Zwillich.;Lynne Napatalung.;Dalia Wajsbrot.;Rana Fayyad.;Amy Freyman.;Debanjali Mitra.;Vivek Purohit.;Rodney Sinclair.;Robert Wolk.
来源: Lancet. 2023年401卷10387期1518-1529页
Alopecia areata is characterised by non-scarring loss of scalp, face, or body hair. We investigated the efficacy and safety of ritlecitinib, an oral, selective dual JAK3/TEC family kinase inhibitor, in patients with alopecia areata.

4262. Women's health, Inc.

作者: Joseph Dov Bruch.;Sarah S Richardson.
来源: Lancet. 2023年401卷10384期1258-1259页

4263. Calls for transparency in pandemic accord talks.

作者: Talha Burki.
来源: Lancet. 2023年401卷10384期1255页

4264. UK infected blood inquiry releases compensation report.

作者: Jacqui Thornton.
来源: Lancet. 2023年401卷10384期1252-1254页

4265. Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?

作者: Christoph Hochmayr.;Michael Auckenthaler.;Franz-Martin Fink.;Ursula Kiechl-Kohlendorfer.;Elke Griesmaier.
来源: Lancet. 2023年401卷10384期e20页

4266. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

作者: .; .
来源: Lancet. 2023年401卷10384期1277-1292页
Anthracycline-taxane chemotherapy for early-stage breast cancer substantially improves survival compared with no chemotherapy. However, concerns about short-term and long-term side-effects of anthracyclines have led to increased use of taxane chemotherapy without anthracycline, which could compromise efficacy. We aimed to better characterise the benefits and risks of including anthracycline, and the comparative benefits of different anthracycline-taxane regimens.

4267. Department of Error.

来源: Lancet. 2023年401卷10384期1266页

4268. Department of Error.

来源: Lancet. 2023年401卷10384期1266页

4269. Helicobacter pylori eradication and aspirin: a puzzle yet to be solved - Author's reply.

作者: Chris Hawkey.; .
来源: Lancet. 2023年401卷10384期1266页

4270. Skin lesion specimens as first choice to detect monkeypox virus - Authors' reply.

作者: Markus Müller.;Barbara Ingold-Heppner.;Hartmut Stocker.;Frank L Heppner.;Carsten Dittmayer.;Michael Laue.
来源: Lancet. 2023年401卷10384期1265页

4271. Helicobacter pylori eradication and aspirin: a puzzle yet to be solved.

作者: Luigi Gatta.;Angelo Zullo.;Dino Vaira.
来源: Lancet. 2023年401卷10384期1265-1266页

4272. The emergence of mpox as an HIV-related opportunistic infection.

作者: Jesse O'Shea.;Demetre Daskalakis.;John T Brooks.
来源: Lancet. 2023年401卷10384期1264页

4273. Skin lesion specimens as first choice to detect monkeypox virus.

作者: Ya Bin Zhou.
来源: Lancet. 2023年401卷10384期1264-1265页

4274. Why vaccinations should be a top priority in earthquake relief efforts.

作者: Omar Alomari.
来源: Lancet. 2023年401卷10384期1263-1264页

4275. Addressing a potential crisis in the Italian National Health System.

作者: Arianna Magon.;Rosario Caruso.
来源: Lancet. 2023年401卷10384期1262-1263页

4276. Characteristics of the omicron XBB subvariant wave in Singapore.

作者: Alvin Xie Cheng Goh.;Sae-Rom Chae.;Calvin J Chiew.;Nicole Tang.;Deanette Pang.;Cui Lin.;Kelvin Bryan Tan.;Vernon J Lee.;Zheng Jie Marc Ho.
来源: Lancet. 2023年401卷10384期1261-1262页

4277. Renzo Guinto: creating resilient planetary systems for health.

作者: Aarathi Prasad.
来源: Lancet. 2023年401卷10384期1256页

4278. Offline: How to fail well in global health.

作者: Richard Horton.
来源: Lancet. 2023年401卷10384期1251页

4279. Chemotherapy for early-stage breast cancer: the more the better?

作者: Song-Jie Shen.;Chang-Mei Liu.
来源: Lancet. 2023年401卷10384期1243-1245页

4280. Punishing the tortured: criminalisation of suicide.

作者: The Lancet.
来源: Lancet. 2023年401卷10384期1241页
共有 4674 条符合本次的查询结果， 用时 5.401684 秒